Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Lampasona, Vito ^a   Passerini, Laura ^b   Barzaghi, Federica ^b   Lombardoni, Carlo ^a,c   Bazzigaluppi, Elena ^c   Brigatti, Cristina ^a   Bacchetta, Rosa ^b   Bosi, Emanuele ^a,c,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^c Diagnostica e Ricerca San Raffaele   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HARMONIN ANTIBODY; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; VILLIN ANTIBODY; ACTIN BINDING PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; USH1C PROTEIN, HUMAN; VILLIN;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENTEROPATHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; IPEX SYNDROME; LUMINESCENT IMMUNOPRECIPITATION SYSTEM; PATIENT MONITORING; QUANTITATIVE ASSAY; RELAPSE; REMISSION; SCREENING; SENSITIVITY AND SPECIFICITY; DIAGNOSTIC USE; GENETIC DISEASES, X-LINKED; IMMUNOLOGY; INFANT; INTESTINE CELL; MUTATION; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; ENTEROCYTES; GENETIC DISEASES, X-LINKED; HUMANS; INFANT; INFANT, NEWBORN; MICROFILAMENT PROTEINS; MUTATION; T-LYMPHOCYTES, REGULATORY;

EID: 84892620011     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078664     Document Type: Article

References (48)

1. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, et al. (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature genetics 27: 18-20.
2. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature genetics 27: 20-21.
3. Gambineri E, Perroni L, Passerini L, Bianchi L, Doglioni C, et al. (2008) Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. The Journal of allergy and clinical immunology 122: 1105-1112.e1.
4. Torgerson TR, Ochs HD (2007) Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. The Journal of allergy and clinical immunology 120: 744-50; quiz 751-2.
5. Barzaghi F, Passerini L, Gambineri E, Ciullini Mannurita S, Cornu T, et al. (2012) Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome. Journal of autoimmunity 38: 49-58.
6. Moes N, Rieux-Laucat F, Begue B, Verdier J, Neven B, et al. (2010) Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology 139: 770-778.
7. Mirakian R, Richardson a, Milla PJ, Walker-Smith J a, Unsworth J, et al. (1986) Protracted diarrhoea of infancy: evidence in support of an autoimmune variant. British medical journal (Clinical research ed) 293: 1132-1136.
8. Kobayashi Imamura, Yamada Okano, Yara, etal. (1998) A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy. Clinical and Experimental Immunology 111: 527-531.
9. Kobayashi I, Imamura K, Kubota M, Ishikawa S, Yamada M, et al. (1999) Identification of an autoimmune enteropathy-related 75-kilodalton antigen. Gastroenterology 117: 823-830.
10. Verpy E, Leibovici M, Zwaenepoel I, Liu XZ, Gal a, et al. (2000) A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nature genetics 26: 51-55.
11. Reiners J, Märker T, Jürgens K, Reidel B, Wolfrum U (2005) Photoreceptor expression of the Usher syndrome type 1 protein protocadherin 15 (USH1F) and its interaction with the scaffold protein harmonin (USH1C). Molecular vision 11: 347-355.
12. Reiners J, Van Wijk E, Märker T, Zimmermann U, Jürgens K, et al. (2005) Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. Human molecular genetics 14: 3933-3943.
13. Patey-Mariaud de Serre N, Canioni D, Ganousse S, Rieux-Laucat F, Goulet O, et al. (2009) Digestive histopathological presentation of IPEX syndrome. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc 22: 95-102.
14. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, et al. (1998) Characterization of human colon cancer antigens recognized by autologous antibodies. International Journal of Cancer Journal International Du Cancer 76: 652-658.
15. Friederich E, Vancompernolle K, Louvard D, Curie I, France PC, et al. (1999) Villin Function in the Organization of the Actin Cytoskeleton. 274: 26751-26760.
16. Kobayashi I, Kubota M, Yamada M, Tanaka H, Itoh S, et al. (2011) Autoantibodies to villin occur frequently in IPEX, a severe immune dysregulation, syndrome caused by mutation of FOXP3. Clinical immunology (Orlando, Fla) 141: 83-89.
17. Burbelo PD, Hirai H, Leahy H, Lernmark A, Ivarsson SA, et al. (2008) A New Luminescence Assay for Autoantibodies to Mammalian Cell-Prepared Insulin-oma-Associated Protein 2. Diabetes Care 31: 1824-1826.
18. Passerini L, Di Nunzio S, Gregori S, Gambineri E, Cecconi M, et al. (2011) Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome. European journal of immunology 41: 1120-1131.
19. Mazzolari E, Forino C, Fontana M, D'Ippolito C, Lanfranchi a, et al. (2005) A new case of IPEX receiving bone marrow transplantation. Bone marrow transplantation 35: 1033-1034.
20. Barzaghi F, Passerini L, Bacchetta R (2012) Immune dysregulation, poly-endocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Frontiers in immunology 3: 211.
21. Diabetes DOF (2012) Diagnosis and classification of diabetes mellitus. Diabetes care 35 Suppl 1: S64-71.
22. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, et al. (1998) Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47: 1857-1866.
23. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, et al. (1995) Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38: 816-822.
24. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E (1995) Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. Journal of immunology (Baltimore, Md: 1950) 155: 5419-5426.
25. Naserke HE, Dozio N, Ziegler AG, Bonifacio E (1998) Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 41: 681-683.
26. Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, et al. (2010) Zinc Transporter 8 Antibodies Complement GAD and IA-2 Antibodies in the Identification and Characterization of Adult-Onset Autoimmune Diabetes. Diabetes Care 33: 104-108.
27. Bazzigaluppi E, Lampasona V, Barera G, Venerando A, Bianchi C, et al. (1999) Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease. Journal of autoimmunity 12: 51-56.
28. Piquer S, Belloni C, Lampasona V, Bazzigaluppi E, Vianello M, et al. (2005) Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association. Clinical immunology (Orlando, Fla) 117: 31-35.
29. Soderbergh A, Myhre AG, Ekwall O, Gebre-Medhin G, Hedstrand H, et al. (2004) Prevalence and Clinical Associations of 10 Defined Autoantibodies in Autoimmune Polyendocrine Syndrome Type I. J Clin Endocrinol Metab 89: 557-562.
30. Participating Laboratories, Schlosser M, Mueller PW, Törn C, Bonifacio E, et al. (2010) Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia 53: 2611-2620.
31. Lampasona V, Schlosser M, Mueller PW, Williams AJK, Wenzlau JM, et al. (2011) Diabetes Antibody Standardization Program: First Proficiency Evaluation of Assays for Autoantibodies to Zinc Transporter 8. Clinical chemistry 1702.
32. Li M, Yu L, Tiberti C, Bonamico M, Taki I, et al. (2009) A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. The American Journal of Gastroenterology 104: 154-163.
33. Burbelo PD, Hirai H, Issa AT, Kingman A, Lernmark A, et al. (2010) Comparison of radioimmunoprecipitation with luciferase immunoprecipitation for autoantibodies to GAD65 and IA-2beta. Diabetes care 33: 754-756.
34. Burbelo PD, Leahy HP, Issa AT, Groot S, Baraniuk JN, et al. (2009) Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome. Autoimmunity 42: 515-524.
35. Ching KH, Burbelo PD, Tipton C, Wei C, Petri M, et al. (2012) Two major autoantibody clusters in systemic lupus erythematosus. PloS one 7: e32001.
36. Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, et al. (2006) Defective regulatory and effector T cell functions in patients with FOXP3 mutations. 116: 1713-1722.
37. McMurchy AN, Gillies J, Allan SE, Passerini L, Gambineri E, et al. (2010) Point mutants of forkhead box P3 that cause immune dysregulation, poly-endocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells. The Journal of allergy and clinical immunology 126: 1242-1251.
38. Lim HW, Hillsamer P, Kim CH (2004) Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. The Journal of clinical investigation 114: 1640-1649.
39. Lim HW, Hillsamer P, Banham AH, Kim CH (2005) Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. Journal of immunology (Baltimore, Md: 1950) 175: 4180-4183.
40. Zhao D-M, Thornton AM, DiPaolo RJ, Shevach EM (2006) Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 107: 3925-3932.
41. Ludwig-Portugall I, Hamilton-Williams EE, Gottschalk C, Kurts C (2008) Cutting edge: CD25+ regulatory T cells prevent expansion and induce apoptosis of B cells specific for tissue autoantigens. Journal of immunology (Baltimore, Md: 1950) 181: 4447-4451.
42. Seo S, Fields ML, Buckler JL, Reed AJ, Mandik-Nayak L, et al. (2002) The impact of T helper and T regulatory cells on the regulation of anti-doublestranded DNA B cells. Immunity 16: 535-546.
43. Hsu W-T, Suen J-L, Chiang B-L (2006) The role of CD4CD25 T cells in autoantibody production in murine lupus. Clinical and experimental immunology 145: 513-519.
44. Iikuni N, Lourenço E V, Hahn BH, La Cava A (2009) Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus. Journal of immunology (Baltimore, Md: 1950) 183: 1518-1522.
45. Kang SM, Jang E, Paik D-J, Jang Y-J, Youn J (2008) CD4+CD25+ regulatory T cells selectively diminish systemic autoreactivity in arthritic K/BxN mice. Molecules and cells 25: 64-69.
46. Leonardo SM, Josephson J a, Hartog NL, Gauld SB (2010) Altered B cell development and anergy in the absence of Foxp3. Journal of immunology (Baltimore, Md: 1950) 185: 2147-2156.
47. Jang E, Cho WS, Cho M-L, Park H-J, Oh H-J, et al. (2011) Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells. Journal of immunology (Baltimore, Md: 1950) 186: 1546-1553.
48. Kinnunen T, Chamberlain N, Morbach H, Choi J, Kim S, et al. (2013) Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells. Blood 121: 1595-1603.